The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing (20 - 21) Manufacture of chemicals and pharmaceuticals 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations 21.20 - Manufacture of pharmaceutical preparations
225 jobs Number of planned job losses
Announcement Date
28 November 2023
Employment effect (start)
1 January 2024
Foreseen end date
31 December 2025
Description
The management of Recipharm has announced that it will cease operations at its Monts site during 2025. The gradual decline in production had already led the company to announce a voluntary redundancy plan for 95 employees in April 2023 FR-Recipharm-2023a.
Management has announced its priority to actively seek a buyer for the site. The site had benefited from investment to produce the Moderna vaccine at the time of Covid-19, but currently it is suffering from profitability problems. The group benefited from state aid of €35 million out of a total investment of €50 million. According to Henri Alfandari, the Horizons MP for Indre-et-Loire, as cited by France Bleu Touraine, the group, which only received €15 million, is obligated to reimburse the funds. Given this prospect, an effect on employment is already expected, with natural departures that will not be replaced. The majority of job losses will occur in 2025.
Eurofound (2023), Recipharm Monts, Closure in France, factsheet number 200657, European Restructuring Monitor. Dublin, https://apps.eurofound.europa.eu/restructuring-events/detail/200657.
Eurofound’s ERM restructuring legislation database offers an overview of key restructuring-related regulations in the EU Member States and Norway. Its content is continuously updated to reflect any changes made by national legislators in response to, for instance, policy shifts, legal...
Can Europe still achieve its ambitions for battery manufacturing? To answer this, the article looks at data from Eurofound’s European Restructuring Monitor and explores what recent large-scale restructuring events reveal about the state of play in the EU battery sector.
This working paper offers a comprehensive methodological overview of the European Restructuring Monitor (ERM) databases. Even though the methodology has not changed over time, new categories have been added, and the way it has been used by researchers and policymakers...
This Eurofound research paper explores key trends in restructuring in recent years, highlighting the companies that announced the largest job losses and job gains in the EU. It builds on an analysis of company announcements recorded in Eurofound’s European Restructuring...
In 2023, thousands of workers in big tech lost their jobs. Meta, Amazon, Google, Apple, Microsoft and Salesforce had been considered to offer good and secure jobs up to this point. Giants of the information and communication technology (ICT) sector,...
In 2024, the automotive sector in the EU came to the fore in public and policy discussions. The focus was on the slowdown in electric vehicle (EV) sales, rising global competition, belated investments in new technologies, and the potential closure...